Literature DB >> 8476423

A chicken embryo model to study the growth of human uveal melanoma.

G P Luyten1, C M Mooy, P T De Jong, A T Hoogeveen, T M Luider.   

Abstract

In vitro cultured human uveal and skin melanoma cells were injected into the chicken embryonal eye at a stage when the immune system was not yet mature. The melanoma cells were accepted as part of the organism by the host. Even single melanoma cells could be traced by morphological methods as well as by immunohistochemical markers, such as S100, HMB-45, NKI/C3 and HNK-1. We found tumors in 20 and 40 percent of the embryos injected with uveal melanoma and skin melanoma, respectively. The embryos did not exhibit abnormal development of the eye as a result of the microinjection and had a high survival rate (90 and 60%, respectively) during embryogenesis. With this model for uveal melanoma the growth and possibly the metastatic behavior of human uveal melanoma cells can be studied.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476423     DOI: 10.1006/bbrc.1993.1376

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  The chick eye in vision research: An excellent model for the study of ocular disease.

Authors:  C Ellis Wisely; Javed A Sayed; Heather Tamez; Chris Zelinka; Mohamed H Abdel-Rahman; Andy J Fischer; Colleen M Cebulla
Journal:  Prog Retin Eye Res       Date:  2017-06-28       Impact factor: 21.198

Review 2.  Use of the Chick Embryo Model in Uveal Melanoma.

Authors:  Helen Kalirai; Haleh Shahidipour; Sarah E Coupland; Gregorius Luyten
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

3.  Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.

Authors:  C M Mooy; G P Luyten; P T de Jong; T M Luider; T Stijnen; F van de Ham; C C van Vroonhoven; F T Bosman
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype.

Authors:  Alan L Ho; Elgilda Musi; Grazia Ambrosini; Jayasree S Nair; Shyamprasad Deraje Vasudeva; Elisa de Stanchina; Gary K Schwartz
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

5.  Effect of heparan sulfate and gold nanoparticles on muscle development during embryogenesis.

Authors:  Marlena Zielinska; Ewa Sawosz; Marta Grodzik; Mateusz Wierzbicki; Maria Gromadka; Anna Hotowy; Filip Sawosz; Andrzej Lozicki; Andrè Chwalibog
Journal:  Int J Nanomedicine       Date:  2011-12-06

Review 6.  The biology of uveal melanoma.

Authors:  Adriana Amaro; Rosaria Gangemi; Francesca Piaggio; Giovanna Angelini; Gaia Barisione; Silvano Ferrini; Ulrich Pfeffer
Journal:  Cancer Metastasis Rev       Date:  2017-03       Impact factor: 9.264

7.  The Potential Use of Electrochemotherapy in the Treatment of Uveal Melanoma: In Vitro Results in 3D Tumor Cultures and In Vivo Results in a Chick Embryo Model.

Authors:  Miltiadis Fiorentzis; Arne Viestenz; Udo Siebolts; Berthold Seitz; Sarah E Coupland; Joana Heinzelmann
Journal:  Cancers (Basel)       Date:  2019-09-11       Impact factor: 6.639

8.  The chick embryo as an experimental system for melanoma cell invasion.

Authors:  Christian Busch; Jelena Krochmann; Ulrich Drews
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

9.  Optimisation of the Chicken Chorioallantoic Membrane Assay in Uveal Melanoma Research.

Authors:  Ekaterina A Sokolenko; Utta Berchner-Pfannschmidt; Saskia C Ting; Kurt W Schmid; Nikolaos E Bechrakis; Berthold Seitz; Theodora Tsimpaki; Miriam Monika Kraemer; Miltiadis Fiorentzis
Journal:  Pharmaceutics       Date:  2021-12-22       Impact factor: 6.321

10.  Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.

Authors:  Riyue Bao; Oliver Surriga; Daniel J Olson; Jacob B Allred; Carrie A Strand; Yuanyuan Zha; Timothy Carll; Brian W Labadie; Bruno R Bastos; Marcus Butler; David Hogg; Elgilda Musi; Grazia Ambrosini; Pamela Munster; Gary K Schwartz; Jason J Luke
Journal:  Melanoma Res       Date:  2021-02-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.